FGF2 and endometrial cancer: Consequently, AKT-mediated NF-κB activation in endometrial cancer has been shown to increase Cyclooxygenase-2 (COX-2) expression as well as estradiol-mediated vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) [67,68].